Inherited Metaphyseal Dysplasias | Spared Epiphyses & Spine | Not Rickets
MCD SUBTYPES
Critical Must-Knows
- MCD affects metaphyses only — epiphyses and spine are spared (key vs SED)
- Schmid type: most common, AD, COL10A1, normal biochemistry — must differentiate from rickets
- Jansen type: PTH1R constitutive activation causes hypercalcaemia with suppressed PTH
- McKusick (cartilage-hair hypoplasia): AR, immune deficiency, lymphoma risk, Hirschsprung association
- Biochemistry is NORMAL in all types except Jansen (hypercalcaemia) — the critical discriminator from rickets
Clinical Pearls
- "Metaphyseal dysplasia + normal biochemistry = NOT rickets, think MCD
- "Schmid = COL10A1, Jansen = PTH1R, McKusick = RMRP
- "McKusick type has EXTRA-SKELETAL features (hair, immunity, gut, malignancy)
- "Spine and epiphyses SPARED in all MCD types — if involved, consider SED instead
Clinical Imaging
Radiographic Features of Metaphyseal Chondrodysplasia
Key imaging findings that differentiate MCD from other skeletal dysplasias and rickets:
Schmid Type Radiographs
- Metaphyses: irregular, widened, flared with sclerotic and cystic changes
- Growth plates: appear widened (especially at hips, knees, ankles)
- Femoral necks: coxa vara with horizontal growth plates
- Long bones: anterior bowing of femurs and tibiae
- Epiphyses: normal (key discriminator from SED)
- Spine: normal (key discriminator from SED and mucopolysaccharidoses)
Jansen Type Radiographs
- Metaphyses: severely expanded, irregular, "crumpled" or "fragmented" appearance
- Growth plates: markedly disorganised
- Diaphyses: thin cortices, osteopenia from hypercalcaemia
- Skull: thickened cranial vault, hyperostosis
- Epiphyses and spine: normal
- Changes may mimic hyperparathyroidism (subperiosteal resorption)
McKusick / CHH Radiographs
- Metaphyses: cupped, flared, scalloped with irregular ossification
- Hands: short tubular bones, cone-shaped epiphyses (distinctive)
- Ribs: anterior flaring ("cupped" costochondral junctions)
- Spine and epiphyses: normal
- Ligamentous laxity: may cause joint subluxations
MCD vs Rickets on X-ray
- Rickets: metaphyseal cupping, fraying, splaying + looser zones + generalized osteopenia
- MCD: metaphyseal irregularity but no looser zones, no osteomalacia, localised to growth plates
- Key: MCD changes are isolated to metaphyses; rickets has diffuse bone changes
- Biochemistry confirms: rickets shows abnormal Ca, PO4, ALP, vitamin D; Schmid MCD is normal
Critical Metaphyseal Chondrodysplasia Exam Points
Not Rickets
Normal biochemistry in Schmid and McKusick types. A child with metaphyseal irregularity and normal Ca, PO4, ALP, and vitamin D does NOT have rickets. This is the single most tested discriminator.
Spared Epiphyses
Epiphyses and spine are normal in all MCD types. If epiphyses are abnormal or spine shows platyspondyly, consider SED, not MCD. The "spine-sparing" pattern is pathognomonic for the MCD group.
Jansen Hypercalcaemia
Jansen type causes hypercalcaemia from constitutive PTH1R activation. PTH levels are suppressed (not elevated) because the receptor is active independently of PTH. This differentiates it from primary hyperparathyroidism.
McKusick Extra-Skeletal
Cartilage-hair hypoplasia has systemic features: fine sparse hair, cellular immune deficiency, increased malignancy risk (especially lymphoma), Hirschsprung disease. A child with metaphyseal dysplasia AND immune problems = McKusick type.
Quick Decision Guide
| Presentation | Diagnosis | Treatment | Key Pearl |
|---|---|---|---|
| Child with bowed legs, waddling gait, short stature, normal biochemistry | Schmid metaphyseal chondrodysplasia (AD, COL10A1) | Observation, corrective osteotomy for significant deformity | Most common MCD; epiphyses and spine normal |
| Infant with severe dwarfism, hypercalcaemia, metaphyseal disorganisation | Jansen metaphyseal chondrodysplasia (AD, PTH1R) | Bisphosphonates for hypercalcaemia, orthopaedic surveillance | Constitutive PTH receptor activation; PTH suppressed |
| Child with short stature, fine hair, recurrent infections | McKusick / cartilage-hair hypoplasia (AR, RMRP) | Immune monitoring, malignancy screening, orthopaedic care | Extra-skeletal features (hair, immunity, gut) are key |
SJMMCD Types and Genetics
| S | Schmid = COL10A1 Most common MCD; Type X collagen defect; AD inheritance; coxa vara, genu varum |
| J | Jansen = PTH1R Constitutive PTH receptor activation; hypercalcaemia with LOW PTH; most severe MCD |
| M | McKusick = RMRP Cartilage-hair hypoplasia; AR inheritance; immune deficiency, fine hair, malignancy risk |
| S | Schmid = COL10A1 Most common MCD; Type X collagen defect; AD inheritance; coxa vara, genu varum |
| J | Jansen = PTH1R Constitutive PTH receptor activation; hypercalcaemia with LOW PTH; most severe MCD |
| M | McKusick = RMRP Cartilage-hair hypoplasia; AR inheritance; immune deficiency, fine hair, malignancy risk |
Hook:SJM: Schmid-Jansen-McKusick — learn the gene for each type!
NORMDifferentiating MCD from Rickets
| N | Normal labs Calcium, phosphate, ALP, vitamin D are all normal in Schmid and McKusick MCD |
| O | Only metaphyses Changes are confined to metaphyses; epiphyses and spine are spared |
| R | No rachitic features No looser zones, no craniotabes, no widened fontanelles, no osteomalacia |
| M | Metaphyseal sclerosis MCD metaphyses may show sclerosis and cysts (not just cupping/fraying like rickets) |
| N | Normal labs Calcium, phosphate, ALP, vitamin D are all normal in Schmid and McKusick MCD | R | No rachitic features No looser zones, no craniotabes, no widened fontanelles, no osteomalacia |
| O | Only metaphyses Changes are confined to metaphyses; epiphyses and spine are spared | M | Metaphyseal sclerosis MCD metaphyses may show sclerosis and cysts (not just cupping/fraying like rickets) |
Hook:NORM labs = NOT rickets — think Metaphyseal Chondrodysplasia!
HAIMMcKusick (CHH) Extra-Skeletal Features
| H | Hair Fine, sparse, light-coloured hair (cartilage-hair hypoplasia) |
| A | Anaemia Macrocytic anaemia in some patients, may be severe in infancy |
| I | Immune deficiency Combined T-cell and B-cell defects; recurrent infections; impaired vaccine responses |
| M | Malignancy Increased risk of lymphoma (especially non-Hodgkin), leukaemia; also Hirschsprung disease |
| H | Hair Fine, sparse, light-coloured hair (cartilage-hair hypoplasia) | I | Immune deficiency Combined T-cell and B-cell defects; recurrent infections; impaired vaccine responses |
| A | Anaemia Macrocytic anaemia in some patients, may be severe in infancy | M | Malignancy Increased risk of lymphoma (especially non-Hodgkin), leukaemia; also Hirschsprung disease |
Hook:HAIM: Hair-Anaemia-Immune-Malignancy — the systemic features that make McKusick unique!
Overview and Epidemiology
Why This Matters
Metaphyseal chondrodysplasias are a heterogeneous group of inherited skeletal dysplasias characterised by abnormal endochondral ossification at the metaphyses. They are frequently misdiagnosed as rickets or child abuse (metaphyseal fractures) because of overlapping radiographic appearances. Correct identification hinges on recognising the pattern of isolated metaphyseal involvement with normal biochemistry and spared epiphyses and spine. Each subtype has distinct genetics, systemic features, and management implications.
Definition
- Group of genetically heterogeneous skeletal dysplasias
- Characterised by irregular metaphyseal ossification with normal epiphyses and spine
- Result from defects in genes controlling endochondral ossification at the growth plate
- All types cause short stature of varying severity
Epidemiology
- Schmid type: most common MCD; exact incidence unknown but likely under-diagnosed
- Jansen type: extremely rare (fewer than 30 reported cases worldwide)
- McKusick / CHH: highest prevalence in Finnish (approximately 1 in 23,000) and Old Order Amish populations due to founder effects
- Overall MCD prevalence: approximately 1 in 50,000 to 1 in 100,000 live births
Pathophysiology
Growth Plate Biology and MCD
Metaphyseal chondrodysplasias result from disruption of the physis (growth plate), specifically the zone of hypertrophy and the transition from cartilage to bone. The growth plate has distinct zones: resting, proliferative, hypertrophic, and calcification. In Schmid type, type X collagen (produced by hypertrophic chondrocytes) is defective, impairing matrix mineralisation. In Jansen type, constitutive PTH1R signalling disrupts chondrocyte differentiation. In McKusick type, the RMRP gene affects ribosomal RNA processing, impairing chondrocyte proliferation. Despite different mechanisms, all three produce the characteristic pattern of metaphyseal irregularity with preserved epiphyses.
Pathophysiology by MCD Subtype
| Feature | Schmid Type | Jansen Type | McKusick / CHH |
|---|---|---|---|
| Gene | COL10A1 (chromosome 6q21) | PTH1R (chromosome 3p21) | RMRP (chromosome 9p13) |
| Protein / Function | Type X collagen (hypertrophic chondrocyte matrix) | PTH/PTHrP receptor (chondrocyte differentiation) | Mitochondrial RNA-processing endoribonuclease |
| Inheritance | Autosomal dominant | Autosomal dominant | Autosomal recessive |
| Growth plate zone affected | Hypertrophic zone (matrix mineralisation) | Proliferative to hypertrophic transition | Chondrocyte proliferation (all zones) |
| Systemic effects | None (skeletal only) | Hypercalcaemia (constitutive receptor activation) | Hair, immune system, gut, haematopoietic |
Why Epiphyses Are Spared
The epiphyses develop through a secondary ossification centre that is mechanistically separate from the physis. MCD gene defects primarily disrupt the physis (primary growth plate between metaphysis and epiphysis), not the epiphyseal ossification centre itself. This explains the characteristic pattern of metaphyseal abnormality with normal epiphyses.
Why Spine Is Normal
Vertebral body growth occurs through a ring apophysis rather than a conventional physis. The columnar architecture of the vertebral growth plate differs from that of long bones, making it relatively resistant to the metabolic effects of COL10A1, PTH1R, and RMRP mutations. Platyspondyly suggests SED or a mucopolysaccharidosis, NOT MCD.
Classification and Types
Schmid Metaphyseal Chondrodysplasia
Inheritance: Autosomal dominant | Gene: COL10A1 | Protein: Type X collagen
Epidemiology: Most common MCD subtype. Often presents between ages 2 and 5 years when the child begins walking and bowing becomes apparent.
| Feature | Detail |
|---|---|
| Genetics | AD; COL10A1 on 6q21; encodes alpha-1 chain of type X collagen; typically missense mutations in the C-terminal NC1 domain |
| Clinical onset | Age 2-5 years (when weight-bearing begins); may be detected earlier in familial cases |
| Stature | Mild to moderate short stature (final height typically 135-155 cm) |
| Key features | Coxa vara, genu varum (bow legs), anterior femoral bowing, waddling gait, widened metaphyses, flared ankles and wrists |
| Biochemistry | COMPLETELY NORMAL — Ca, PO4, ALP, vitamin D all within reference range |
| Extra-skeletal | NONE — purely skeletal condition; normal intelligence, normal lifespan |
The key exam discriminator: a child with metaphyseal irregularity and completely normal biochemistry does NOT have rickets. Consider Schmid MCD.
Clinical Assessment
History
- Family history: AD (Schmid, Jansen) vs AR (McKusick) pattern
- Age of onset: Schmid age 2-5, Jansen neonatal, McKusick 6-12 months
- Gait: Waddling (coxa vara), bowing progression
- Hair: Fine, sparse, light-coloured (McKusick)
- Infections: Recurrent sinopulmonary infections (McKusick immune deficiency)
- Growth: Birth weight often normal; growth falls off curves post-natally
Examination
- Stature: Measure and plot (short-limbed vs short-trunk)
- Lower limbs: Genu varum, coxa vara, anterior femoral bowing, waddling gait
- Upper limbs: Wide wrists, limited elbow extension (Schmid)
- Hair: Inspect for fine, sparse, hypopigmented hair (McKusick)
- Spine: Normal (if abnormal, reconsider diagnosis — think SED)
- Joints: Ligamentous laxity (McKusick), range of motion
Red Flags Reconsidering the Diagnosis
If any of the following are present, reconsider MCD and broaden the differential:
- Epiphyseal involvement (irregular, fragmented epiphyses) = consider SED, multiple epiphyseal dysplasia, or mucopolysaccharidosis
- Spinal abnormalities (platyspondyly, odontoid hypoplasia) = consider SED, mucopolysaccharidosis, or spondylo-metaphyseal dysplasia
- Abnormal biochemistry (low Ca, low PO4, high ALP) = likely rickets, not MCD
- Craniofacial dysmorphism with rhizomelia = consider achondroplasia (large head, trident hand, frontal bossing, FGFR3 mutation)
- Periosteal reaction / multiple fractures = consider non-accidental injury or osteogenesis imperfecta
Differential Diagnosis of Metaphyseal Irregularity in Children
| Condition | Metaphyses | Epiphyses | Spine | Biochemistry | Key Discriminator |
|---|---|---|---|---|---|
| Schmid MCD | Irregular, flared, sclerotic | Normal | Normal | Normal | AD family history, COL10A1, coxa vara |
| Rickets (nutritional) | Cupped, frayed, splayed | Normal (late widening) | Normal | Abnormal (low Ca/PO4, high ALP) | Biochemistry is ALWAYS abnormal |
| Hypophosphataemic rickets | Metaphyseal changes similar to MCD | Normal early | Normal | Low PO4, normal Ca, normal PTH | Renal phosphate wasting, PHEX mutation (X-linked) |
| SED (congenita or tarda) | Normal | Delayed, irregular, fragmented | Platyspondyly | Normal | Epiphyses AND spine involved |
| Achondroplasia | Flared, 'ball-in-socket' hip | Normal (may appear delayed) | Lumbar canal stenosis (not platyspondyly) | Normal | Rhizomelic, macrocephaly, trident hand, FGFR3 |
| Osteogenesis imperfecta | May show metaphyseal changes | Normal | Bowing, compression fractures | Normal (except type VI with elevated ALP) | Blue sclerae, fractures, COL1A1/COL1A2 |
The Single Best Discriminator from Rickets
Biochemistry. In Schmid and McKusick MCD, calcium, phosphate, alkaline phosphatase, parathyroid hormone, and vitamin D levels are all completely normal. In rickets, at least one parameter is always abnormal. If a child has metaphyseal changes on X-ray and normal biochemistry, rickets is excluded and you should consider MCD.
Investigations
Investigation Protocol
Views: PA and lateral of knees, hips, wrists; full-length standing lower limb alignment; lateral thoracolumbar spine
Look for: Metaphyseal irregularity, flaring, sclerosis, cysts; coxa vara; femoral and tibial bowing; CONE-SHAPED epiphyses in hands (McKusick)
Critically assess: Are the epiphyses truly normal? Is the spine truly normal? If not, reconsider diagnosis
Essential tests: Serum calcium, phosphate, alkaline phosphatase, PTH, 25-hydroxyvitamin D, creatinine, urea
Schmid / McKusick: All normal (Ca, PO4, ALP, PTH, vitamin D)
Jansen: Hypercalcaemia with suppressed PTH; may have hypercalciuria
If any biochemical abnormality in Ca/PO4/ALP: Work up for rickets, renal osteodystrophy, or metabolic bone disease first
Indication: Confirm suspected diagnosis; differentiate between MCD subtypes; enable genetic counselling and prenatal diagnosis
Schmid: COL10A1 sequencing (targeted gene testing)
Jansen: PTH1R sequencing
McKusick: RMRP sequencing (includes promoter region mutations)
Multigene panel: Skeletal dysplasia gene panel if phenotype unclear
Immunology: Lymphocyte subsets (CD4, CD8, CD19, NK cells), immunoglobulin levels, vaccine response testing
Haematology: Full blood count (macrocytic anaemia), reticulocyte count
Gastrointestinal: Consider rectal biopsy if constipation (exclude Hirschsprung disease)
Ongoing: Annual FBC and immune monitoring lifelong
Investigation Pearl
The two most important initial investigations are plain radiographs (to characterise the pattern of metaphyseal involvement and confirm that epiphyses and spine are normal) and biochemistry (to exclude rickets and identify Jansen hypercalcaemia). Genetic testing confirms the specific subtype and guides counselling.
Management Algorithm
Schmid Type Management
Principle: Orthopaedic management of deformity; no medical treatment required (biochemistry is normal, no systemic disease)
Management Timeline
Confirm: Normal biochemistry + genetic testing (COL10A1)
Counsel: Autosomal dominant inheritance (50 percent transmission risk); normal intelligence and lifespan
Baseline: Document deformity severity with full-length standing radiographs and gait analysis
Physiotherapy: Gait training, strengthening, joint range of motion
Orthotics: May help with gait instability from coxa vara or severe bowing
Monitoring: Annual clinical and radiographic review during growth; monitor coxa vara angle (Hilgenreiner-epiphyseal angle)
Activity: No specific restrictions; encourage normal activity
Coxa vara: Proximal femoral valgus osteotomy if Hilgenreiner-epiphyseal angle greater than 60 degrees or progressive deformity
Genu varum: Proximal tibial or distal femoral corrective osteotomy; consider guided growth (hemiepiphysiodesis) if skeletally immature
Timing: Ideally after growth plates have closed or near skeletal maturity to minimise recurrence
Post-operative: Protected weight-bearing, physiotherapy, long-term follow-up for recurrence
Schmid Surgical Pearl
Corrective osteotomies in Schmid MCD have a significant risk of recurrence during remaining growth. Surgical correction is ideally deferred until near skeletal maturity unless deformity is severe or progressive. Guided growth techniques (hemiepiphysiodesis with plates or staples) may be used in younger children to gradually correct angular deformity without osteotomy.
Complications
| Complication | MCD Type | Risk Factors | Management |
|---|---|---|---|
| Progressive coxa vara | Schmid | Severe Hilgenreiner-epiphyseal angle, continued growth | Valgus osteotomy; monitor angle during growth |
| Recurrent deformity after osteotomy | Schmid | Surgery performed too early (active growth plates) | Time surgery near skeletal maturity; use guided growth in younger children |
| Nephrocalcinosis and renal impairment | Jansen | Persistent hypercalcaemia, hypercalciuria | Aggressive calcium control, bisphosphonates, renal monitoring |
| Severe immune deficiency / SCID | McKusick | Profound T-cell deficiency, null mutations in RMRP | HSCT referral, infection prophylaxis, immunoglobulin replacement |
| Lymphoma / leukaemia | McKusick | Immune surveillance failure, cumulative risk increases with age | Annual surveillance, family education, prompt investigation of symptoms |
| Severe anaemia | McKusick | Macrocystic anaemia in infancy, may be life-threatening | Transfusion support, usually self-limiting after early childhood |
Misdiagnosis as Rickets
The most common clinical error is treating MCD patients with vitamin D and calcium supplementation for presumed rickets. In Schmid type, this is unnecessary and may cause iatrogenic hypercalcaemia or hypercalciuria. In Jansen type, additional calcium is actively harmful as the patient is already hypercalcaemic. Always confirm biochemistry before treating metaphyseal changes as rickets.
Outcomes and Prognosis
Prognosis by MCD Subtype
| Subtype | Final Height | Function | Life Expectancy | Key Determinant |
|---|---|---|---|---|
| Schmid | 135-155 cm (mild-moderate short stature) | Good; most achieve independent ambulation and normal activity | Normal | Severity of coxa vara and bowing |
| Jansen | Often less than 120 cm (severe dwarfism) | Variable; limited by severe skeletal dysplasia and metabolic complications | Reduced (renal complications, hypercalcaemia) | Degree of hypercalcaemia control |
| McKusick / CHH | 110-135 cm (moderate-severe short stature) | Good with appropriate immune and orthopaedic management | Reduced (malignancy, severe immune deficiency) | Immune function and malignancy surveillance |
Prognostic Factors
Schmid: Best prognosis of all MCD types. Normal lifespan and intelligence. Main morbidity is orthopaedic (coxa vara, bowing).
Jansen: Worst prognosis. Severe dwarfism, metabolic complications from hypercalcaemia, possible deafness.
McKusick: Variable. Main mortality risk is malignancy (especially lymphoma) and severe immune deficiency. With modern immune support and malignancy surveillance, many patients reach adulthood.
Evidence Base and Key Trials
A type X collagen mutation causes Schmid metaphyseal chondrodysplasia
- First identification of COL10A1 mutations as the cause of Schmid metaphyseal chondrodysplasia
- Linkage analysis mapped the disease locus to chromosome 6q21-q22.3
- Demonstrated that mutations in the C-terminal NC1 domain of type X collagen disrupt trimer assembly
- Established the molecular basis for the most common metaphyseal chondrodysplasia
A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia
- Identified activating mutations in PTH1R as the molecular cause of Jansen metaphyseal chondrodysplasia
- Mutations cause ligand-independent (constitutive) signalling through the PTH/PTHrP receptor
- Explained the paradox of hypercalcaemia with suppressed PTH levels
- Demonstrated that the receptor is active in both kidney and bone, driving calcium release
Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia
- Identified RMRP mutations as the cause of cartilage-hair hypoplasia (McKusick type MCD)
- The same founder mutation (A70G) is present in both Finnish and Amish populations
- RMRP encodes the RNA component of the mitochondrial RNA-processing endoribonuclease (RNase MRP)
- Mutations impair ribosomal RNA processing and cell cycle control in chondrocytes
Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma
- Extended Finnish CHH cohort follow-up confirmed a 90-fold increased risk of non-Hodgkin lymphoma compared to the general population
- Basal cell carcinoma incidence was also significantly elevated
- Immune deficiency severity correlated with malignancy risk
- Combined immune deficiency (T-cell and B-cell defects) was the strongest predictor of adverse outcomes
A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia
- Identified a novel PTH1R mutation (H223R) in Jansen metaphyseal chondrodysplasia, expanding the mutational spectrum
- Confirmed that heterozygous activating mutations in PTH1R are the universal cause of Jansen MCD across all reported families
- Hypercalcaemia severity correlates with the degree of constitutive receptor activation
- Demonstrated that the mutant receptor signals through both cAMP and inositol phosphate pathways
Exam Viva Scenarios
Use these scenarios to practise clinical reasoning and management decisions
Scenario 1: Child with Bowed Legs and Normal Biochemistry
"A 4-year-old boy presents with progressive bilateral genu varum, a waddling gait, and short stature. His parents are unaffected. Biochemistry reveals normal calcium, phosphate, alkaline phosphatase, PTH, and vitamin D. Pelvis and knee radiographs show coxa vara with irregular, flared metaphyses. The epiphyses and spine appear normal. What is the diagnosis and how would you manage this child?"
Scenario 2: Infant with Short Limbs, Fine Hair, and Recurrent Pneumonias
"An 18-month-old girl of Finnish descent presents with short-limbed short stature, recurrent lower respiratory tract infections, and chronically loose stools. Examination reveals fine, sparse, light-coloured hair, ligamentous laxity, and bilateral genu varum. Hand radiographs show short metacarpals with cone-shaped epiphyses. Knee radiographs show flared metaphyses with normal epiphyses. What is the diagnosis, what investigations are needed, and how would you manage her?"
MCQ Practice Points
Genetics Question
Q: Which gene is mutated in Schmid metaphyseal chondrodysplasia? A: COL10A1, located on chromosome 6q21. This gene encodes the alpha-1 chain of type X collagen, which is specifically expressed by hypertrophic chondrocytes in the growth plate. Mutations (typically in the NC1 domain) disrupt trimer assembly and impair endochondral ossification at the metaphysis, producing the characteristic metaphyseal irregularity while sparing the epiphyses and spine.
Biochemistry Question
Q: What is the biochemical profile in Schmid metaphyseal chondrodysplasia? A: Completely normal. Calcium, phosphate, alkaline phosphatase, parathyroid hormone, and 25-hydroxyvitamin D are all within normal limits. This is the critical discriminator from rickets, where at least one parameter is always abnormal. Treating a child with Schmid MCD with vitamin D is unnecessary and potentially harmful.
Jansen Type Question
Q: Why is PTH suppressed in Jansen metaphyseal chondrodysplasia despite hypercalcaemia? A: Constitutive activation of the PTH1R receptor. The mutation causes ligand-independent receptor signalling, producing the biological effects of PTH (calcium release from bone, renal calcium reabsorption) without requiring PTH binding. The resulting hypercalcaemia then suppresses parathyroid gland PTH secretion via negative feedback, producing the characteristic pattern of high calcium with low PTH.
Differential Diagnosis Question
Q: How do you differentiate metaphyseal chondrodysplasia from rickets on clinical and biochemical grounds? A: Biochemistry is the key. In rickets, calcium and/or phosphate are low, ALP is elevated, and vitamin D is low (nutritional) or phosphate is low with normal Ca (hypophosphataemic). In MCD (Schmid and McKusick), ALL biochemical parameters are normal. Radiologically, both show metaphyseal changes, but rickets also produces looser zones, craniotabes, and generalized osteopenia, which are absent in MCD.
McKusick Question
Q: What extra-skeletal features distinguish McKusick (cartilage-hair hypoplasia) from other MCD types? A: Fine, sparse, hypopigmented hair; combined immune deficiency (T-cell and B-cell); increased malignancy risk (especially non-Hodgkin lymphoma); macrocytic anaemia; and Hirschsprung disease. These systemic features are unique to the McKusick type and reflect the broader role of the RMRP gene in cell proliferation across multiple tissues, not just cartilage.
Imaging Question
Q: What are the key imaging features that distinguish MCD from spondyloepiphyseal dysplasia (SED)? A: In MCD, the metaphyses are abnormal but the epiphyses and spine are normal. In SED, the epiphyses are irregular, delayed, or fragmented AND the spine shows platyspondyly or other vertebral anomalies. The pattern of involvement (metaphyses only vs epiphyses plus spine) is the fundamental radiographic discriminator.
Guidelines, Registries & Global Practice
Global Epidemiology
- Schmid type: worldwide distribution; likely under-diagnosed as mild cases may be attributed to physiological bowing or familial short stature
- Jansen type: extremely rare globally; no ethnic or geographic concentration
- McKusick / CHH: founder mutations in Finnish (approximately 1 in 23,000 births) and Old Order Amish (Pennsylvania, USA) populations; cases reported worldwide across all ethnicities
- Overall: MCD accounts for a small proportion of skeletal dysplasias; accurate diagnosis requires genetic confirmation
Practice Variation by Resource Setting
- High-resource: multidisciplinary care with geneticists, paediatric orthopaedic surgeons, immunologists, and haematologists; skeletal dysplasia gene panels available
- Limited-resource: clinical and radiographic diagnosis with basic biochemistry; genetic testing may require sample shipment to reference laboratories; orthopaedic management prioritised
- Universal principle: biochemistry (Ca, PO4, ALP) is universally available and is the most important first-line test to differentiate MCD from rickets in all settings
- McKusick surveillance: malignancy and immune monitoring requires infrastructure that may be limited in resource-constrained settings
Society and Reference Guidance (Side by Side)
| Source | Diagnosis | Medical Management | Orthopaedic Management |
|---|---|---|---|
| ESPGN / Paediatric Endocrine Societies | Biochemistry first (exclude rickets); then genetic testing for MCD subtype | Jansen: bisphosphonates for hypercalcaemia; McKusick: immune monitoring and prophylaxis | Referral to paediatric orthopaedics for deformity correction |
| POSNA / Paediatric Orthopaedic Societies | Standing lower limb radiographs + pelvis; classify pattern of metaphyseal involvement | No role for vitamin D/calcium supplementation in MCD with normal biochemistry | Corrective osteotomy for progressive coxa vara (Hilgenreiner angle greater than 60 degrees); guided growth for genu varum |
| ISDS (International Skeletal Dysplasia Society) | Nosology-based classification; genetic confirmation for all MCD subtypes | Multidisciplinary management; McKusick requires immunology and oncology input | Individualised surgical planning; recurrence risk high if surgery before skeletal maturity |
| ESID (European Society for Immunodeficiencies) | McKusick CHH is a recognised combined immune deficiency; lymphocyte subset analysis mandatory | HSCT for severe combined immune deficiency phenotype; IVIG for antibody deficiency | Coordinate orthopaedic surgery with immunological status; avoid live vaccines if T-cell deficient |
Registry and Evidence Note
There is no dedicated international registry for metaphyseal chondrodysplasias, though the Finnish CHH cohort represents one of the best-characterised single-gene skeletal dysplasia populations worldwide. The ISDS maintains a nosology of skeletal dysplasias that classifies MCD subtypes. Evidence is predominantly from case series, cohort studies, and expert reviews rather than randomised controlled trials, owing to the rarity of these conditions.
Avoid Harmful Misdiagnosis (Globally Applicable)
In any child with metaphyseal irregularity on radiographs:
- ALWAYS check biochemistry (Ca, PO4, ALP) before prescribing vitamin D or calcium
- If biochemistry is normal, the diagnosis is NOT rickets — do not treat as rickets
- Consider MCD and refer for genetic testing
- In Jansen type, additional calcium is actively dangerous (patient is already hypercalcaemic)
Misdiagnosis of MCD as rickets leads to unnecessary treatment, delayed appropriate management, and potential harm from iatrogenic hypercalcaemia or hypercalciuria.
Controversies & Areas of Uncertainty
Growth Hormone Therapy in MCD
The role of GH in MCD remains uncertain. Small series suggest modest benefit in McKusick CHH (improved growth velocity without significant side effects), but there is no evidence of benefit in Schmid or Jansen types. GH does not address the underlying growth plate defect. Most guidelines do not routinely recommend GH for MCD.
Optimal Timing of Osteotomy
The ideal timing of corrective osteotomy in Schmid MCD is debated. Operating during active growth carries significant recurrence risk, but delaying surgery until skeletal maturity may allow prolonged deformity with joint compensation issues. Guided growth techniques offer an intermediate solution but long-term data are limited.
Targeted Therapy for Jansen MCD
Calcimimetics and PTH1R antagonists have been proposed as targeted therapies for Jansen hypercalcaemia, but clinical data are extremely limited. Current management relies on bisphosphonates and supportive care. A true targeted approach requires development of a functional PTH1R inhibitor, which does not yet exist in clinical practice.
McKusick Malignancy Surveillance Protocol
The optimal malignancy surveillance protocol for CHH patients is not standardised. Annual clinical examination and FBC is widely practised, but the role of routine imaging (ultrasound, CT) for lymphoma screening is debated due to radiation risk and low positive predictive value in asymptomatic patients. Current practice relies on clinical vigilance and patient education.
METAPHYSEAL CHONDRODYSPLASIA
Clinical summary
Key Genetics
- •Schmid = COL10A1 (type X collagen), AD, chromosome 6q21 — most common MCD
- •Jansen = PTH1R (PTH/PTHrP receptor), AD, chromosome 3p21 — rarest, most severe
- •McKusick / CHH = RMRP (RNase MRP RNA component), AR, chromosome 9p13 — Finnish/Amish founder effect
- •All three affect the growth plate (physis) but spare epiphyses and spine
Clinical Features
- •Schmid: coxa vara, genu varum, bowing, waddling gait, mild-moderate short stature, onset age 2-5
- •Jansen: severe dwarfism, hypercalcaemia, prominent forehead, onset neonatal/infancy
- •McKusick: fine sparse hair, immune deficiency, short limbs, cone-shaped epiphyses in hands, malignancy risk
- •Spine and epiphyses are NORMAL in all MCD types — if abnormal, consider SED
Diagnosis
- •Biochemistry is NORMAL in Schmid and McKusick — the critical discriminator from rickets
- •Jansen has hypercalcaemia with SUPPRESSED PTH (constitutive receptor activation)
- •Radiographs: metaphyseal irregularity, flaring, sclerosis; normal epiphyses and spine
- •Genetic testing confirms subtype: COL10A1, PTH1R, or RMRP sequencing
Management
- •Schmid: orthopaedic only — corrective osteotomy for coxa vara (angle greater than 60 degrees) or severe genu varum
- •Jansen: bisphosphonates for hypercalcaemia, renal monitoring, orthopaedic support
- •McKusick: multidisciplinary — immune monitoring, malignancy surveillance, orthopaedic care, genetic counselling
- •DO NOT treat with vitamin D or calcium unless biochemistry confirms rickets
Differential Diagnosis
- •Rickets: abnormal biochemistry (low Ca, low PO4, high ALP) — MCD has normal labs
- •SED: epiphyses AND spine involved — MCD spares both
- •Achondroplasia: rhizomelic, macrocephaly, FGFR3 — different gene and pattern
- •Hypophosphataemic rickets: low phosphate with renal wasting, PHEX mutation — biochemistry abnormal